T2-GI * IBS(irritable bowel syndrome) formula

Browsing Archive: March, 2013

AstraZeneca, Ironwood will bring irritable bowel syndrome treatment to China

Posted by Adam on Thursday, March 14, 2013, In : IBS 

AstraZeneca and Ironwood are jointly responsible for strategic oversight of the development and commercialization of linaclotide in China. AstraZeneca will have primary responsibility for the local operational execution.
Under the terms of the collaboration, AstraZeneca will make an upfront payment of $25 million to Ironwood and will share the net profits and losses associated with linaclotide in China, with AstraZeneca carrying 55 percent of each until a certain specified milestone is achieve...

Continue reading ...
 

Studying The Causes Of Irritable Bowel Syndrome - GENIEUR

Posted by Adam on Monday, March 11, 2013, In : IBS 
Experts and scientists from 19 European countries are getting together to investigate the causes of IBS (irritable bowel syndrome) with the aim of better understanding the condition and improving diagnosis and treatment.

The team is led by researchers from the Sahlgrenska Academy, University of Gothenburg and Karolinska Institutet, both in Sweden. They have set up the Europe-wide network GENIEUR - an interdisciplinary network for researching into the causes of IBS.

GENIEUR, which stands for Gen...

Continue reading ...
 

Possible Overlap Of IBS Symptoms And Inflammatory Bowel Disease

Posted by Adam on Sunday, March 10, 2013,
Research unveiled at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas suggests a possible overlap of symptoms of two prevalent GI disorders: irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) and further suggests a possible link between subtle GI tract inflammation and IBS symptoms - a link that is also the focus of the first systemic review of the literature on this topic and an editorial both published in this month's American Jou...

Continue reading ...